228544-65-8
Chemical Structure
VULM 1457
- CAS No.: 228544-65-8
- Formula:C25H27N3O3S
- Molecular Weight:449.57
IUPAC Name: 1-(2,6-diisopropylphenyl)-3-(4-((4-nitrophenyl)thio)phenyl)urea
InChIKey: XFFITGBWVLQNCD-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=C(SC2=CC=C([N+]([O-])=O)C=C2)C=C1)NC3=C(C=CC=C3C(C)C)C(C)C
Biological Activity: VULM 1457 is a potent inhibitor of cholesterol acyltransferase (acyl-CoA). VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM 1457 has the potential for the research of diabetes mellitus and hypercholesterolaemia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
VULM 1457 | 99.71% | VULM 1457 is a potent inhibitor of cholesterol acyltransferase (acyl-CoA). VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM 1457 has the potential for the research of diabetes mellitus and hypercholesterolaemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
VULM 1457 (Standard) | VULM 1457 (Standard) is the analytical standard of VULM 1457 (HY-107571). This product is intended for research and analytical applications. VULM 1457 is a potent inhibitor of cholesterol acyltransferase (acyl-CoA). VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM 1457 has the potential for the research of diabetes mellitus and hypercholesterolaemia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.57
HY-160804Desmethyl nevanimibe -
Similarity Score 0.56
HY-107814RNicarbazin (Standard) -
Similarity Score 0.55
HY-100399ARNevanimibe hydrochloride (Standard) -
Similarity Score 0.55
HY-100399Nevanimibe -
Similarity Score 0.54
HY-19753KS176 -
Similarity Score 0.54
HY-102014RN-18 -
Similarity Score 0.54
HY-129986CAI/II-IN-9 -
Similarity Score 0.52
HY-163852HIV-1 inhibitor-72 -
Similarity Score 0.52
HY-168728MAO-B-IN-37 -
Explore the MedChemAI to find more analogs
References
- [1]. J Drímal, et al. The ACAT inhibitor VULM1457 significantly reduced production and secretion of adrenomedullin (AM) and down-regulated AM receptors on human hepatoblastic cells. Gen Physiol Biophys. 2005 Dec;24(4):397-409. [Content Brief]
- [2]. Adameová A, et al. The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and [Content Brief]
